Table of Contents

What Is Structural Biology?

Structural biology is the branch of science devoted to figuring out the three-dimensional shapes of biological molecules — primarily proteins, DNA, and RNA — and understanding how those shapes determine what the molecules do.

Here’s why shape matters so much: a protein is essentially a long chain of amino acids that folds into a specific 3D structure. That structure determines everything about how the protein works. An enzyme’s active site must be exactly the right shape to grab its target molecule. An antibody recognizes a virus because its tip fits the viral surface like a key in a lock. Change the shape, and you change (or destroy) the function.

The Big Three Techniques

X-Ray Crystallography

The oldest and most prolific method. You grow a crystal of your protein (which can take weeks or months of trial and error), then blast it with X-rays. The X-rays scatter off the atoms in predictable patterns, and from those diffraction patterns, you calculate the 3D structure.

This technique gave us the structure of DNA (Watson and Crick’s famous double helix in 1953 relied on Rosalind Franklin’s X-ray crystallography data), hemoglobin, and thousands of other critical molecules. The Protein Data Bank, which stores all publicly available structures, contains over 200,000 entries — and the majority were determined by X-ray crystallography.

The limitation? You need a crystal. Some proteins refuse to crystallize. Membrane proteins — which sit in the cell’s fatty membrane — are notoriously difficult to crystallize and yet are the targets of roughly half of all drugs.

Cryo-Electron Microscopy (Cryo-EM)

Cryo-EM has been around since the 1980s but became revolutionary around 2013 when detector technology caught up. You flash-freeze your sample in a thin layer of ice, then image it with an electron microscope from thousands of different angles. Software combines these images into a 3D reconstruction.

The big advantage: no crystals needed. You can study molecules in near-native conditions, including large molecular machines that would never form crystals. The “resolution revolution” in cryo-EM earned Jacques Dubochet, Joachim Frank, and Richard Henderson the 2017 Nobel Prize in Chemistry.

Nuclear Magnetic Resonance (NMR)

NMR spectroscopy works on molecules in solution — closest to their natural state. It measures how atomic nuclei respond to magnetic fields, revealing distances between atoms and the overall molecular shape.

NMR’s unique strength is capturing molecular motion. Proteins aren’t rigid statues — they flex, breathe, and shift between conformations. NMR can reveal these dynamics in ways that crystallography and cryo-EM cannot. The tradeoff is a size limit: NMR works best on relatively small proteins.

Why This Matters for Medicine

Most drugs work by fitting into a protein’s binding site and altering its activity — blocking it, activating it, or changing its behavior. Knowing the protein’s exact 3D shape lets drug designers create molecules that fit perfectly, like designing a key for a specific lock.

This structure-based drug design has produced some of medicine’s biggest wins. HIV protease inhibitors, which transformed AIDS from a death sentence to a manageable condition, were designed after researchers solved the structure of the HIV protease enzyme. Cancer drugs like imatinib (Gleevec) target specific protein shapes found only in cancer cells.

The COVID-19 response showcased structural biology’s speed. Within weeks of the virus’s emergence, researchers had published the 3D structure of the SARS-CoV-2 spike protein. That structure guided vaccine design and antiviral drug development at unprecedented speed.

The AlphaFold Revolution

For decades, the “protein folding problem” — predicting a protein’s 3D shape from its amino acid sequence — was one of biology’s grand challenges. Then in 2020, DeepMind’s AlphaFold AI system essentially solved it, predicting protein structures with accuracy rivaling experimental methods.

In 2022, AlphaFold predicted structures for virtually every known protein — over 200 million of them. This was staggering. Experimental methods might determine a few hundred new structures per year. AlphaFold did 200 million in one shot.

This doesn’t replace experimental structural biology. AI predictions need experimental validation, and they don’t capture molecular dynamics or drug-binding details as well as experimental methods. But AlphaFold has fundamentally accelerated the field, giving researchers starting models for proteins that might have taken years to study experimentally.

Where the Field Is Heading

The trend is toward studying molecules in increasingly natural contexts — inside living cells, in complex multi-protein assemblies, and in motion. Cryo-electron tomography can image molecules directly inside cells. Time-resolved crystallography captures molecular changes in femtoseconds. Integrative approaches combine data from multiple techniques to build complete pictures of cellular machinery.

Structural biology started with individual molecules. It’s now aiming to understand the structural organization of entire cells — a goal that seemed impossibly ambitious just a decade ago.

Frequently Asked Questions

What is the difference between structural biology and molecular biology?

Molecular biology studies biological processes at the molecular level — how genes are expressed, how proteins are made, how cells signal each other. Structural biology specifically focuses on determining the three-dimensional shapes of molecules and understanding how shape determines function. Think of molecular biology as studying what molecules do, while structural biology studies what they look like.

How did AlphaFold change structural biology?

AlphaFold, developed by DeepMind, uses AI to predict protein structures from their amino acid sequences with remarkable accuracy. Released in 2021, it predicted structures for nearly every known protein — over 200 million structures. This was a breakthrough because experimental structure determination takes months or years per protein, while AlphaFold can predict a structure in minutes.

Why does the shape of a protein matter?

A protein's shape determines its function. Enzymes work because their active site has exactly the right shape to grab a specific molecule. Antibodies recognize viruses because their tips match viral surface proteins like a lock and key. When proteins misfold — take the wrong shape — it can cause diseases like Alzheimer's, Parkinson's, and cystic fibrosis.

Further Reading

• RCSB Protein Data Bank
• Structural Biology - NIH National Institute of General Medical Sciences
• European Molecular Biology Laboratory